IGF-2R-Mediated signaling results in hypertrophy of cultured cardiomyocytes from fetal sheep

Biology of Reproduction

Volumn 86, Issue 6, 2012, Pages 1-8

  Wang, Kimberley C W ^a   Brooks, Doug A ^a   Botting, Kimberley J ^a,b   Morrison, Janna L ^a,b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cell culture; Developmental origins of health and disease; Ovine; Sheep

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; PROTEIN KINASE C INHIBITOR; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; AUTOPHOSPHORYLATION; CARDIAC MUSCLE CELL; CONTROLLED STUDY; ENZYME ACTIVATION; EXPERIMENTAL SHEEP; FETUS; HEART HYPERTROPHY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SERUM-FREE MEDIUM; SIGNAL TRANSDUCTION;

EID: 85006035891     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.112.100388     Document Type: Article

References (55)

1. Levy D, Garrison R, Savage D, Kannel W, Castelli W. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
2. Brown D, Giles W, Croft J. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am Heart J 2000; 140:848-856.
3. Vijayakumar M, Fall CH, Osmond C, Barker DJ. Birth weight, weight at one year, and left ventricular mass in adult life. Br Heart J 1995; 73: 363-367.
4. Ebensperger R, Acevedo E, Melendez J, Corbalan R, Acevedo M, Sapag-Hagar M, Jalil J, Lavandero S. Selective increase in cardiac IGF-1 in a rat model of ventricular hypertrophy. Biochem Biophys Res Commun 1998; 243:20-24.
5. McMullen J, Shioi T, Huang W, Zhang L, Tarnavski O, Bisping E, Schinke M, Kong S, Sherwood M, Brown J, Riggi L, Kang P, et al. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110 alpha) pathway. J Biol Chem 2004; 279:4782-4793.
6. Reiss K, Cheng W, Ferber A, Kajstura J, Li P, Li B, Olivetti G, Homcy C, Baserga R, Anversa P. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation growth in transgenic mice. Proc Natl Acad Sci U S A 1996; 93:8630-8635.
7. Sundgren N, Giraud G, Schultz J, Lasarev M, Stork P, Thornburg K. Extracellular signal-regulated kinase and phosphoinositol-3 kinase mediate IGF-1 induced proliferation of fetal sheep cardiomyocytes. Am J Physiol Regul Integr Comp Physiol 2003; 285:R1481-R1489.
8. Menu E, Jernberg-Wiklund H, Stromberg T, De Raeve H, Girnita L, Larsson O, Axelson M, Asosingh K, Nilsson K, Van Camp B, Vanderkerken K. Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model. Blood 2006; 107:655-660.
9. Lumbers E, Kim M, Burrell J, Kumarasamy V, Boyce A, Gibson K, Gatford K, Owens J. Effects of intrafetal IGF-I on growth of cardiac myocytes in late-gestation fetal sheep. Am J Physiol Endocrinol Metab 2009; 296:E513-E519.
10. Woodcock EA, Matkovich SJ. Cardiomyocytes structure, function and associated pathologies. Int J Biochem Cell Biol 2005; 37:1746-1751.
11. Morrison J, Botting K, Dyer J, Williams S, Thornburg K, McMillen I. Restriction of placental function alters heart development in the sheep fetus. Am J Physiol Regul Integr Comp Physiol 2007; 293:R306-R313.
12. Girnita A, Girnita L, del Prete F, Bartolazzi A, Larsson O, Axelson M. Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth. Cancer Res 2004; 64:236-242.
13. Favata M, Horiuchi K, Manos E, Daulerio A, Stradley D, Feeser W, Van Dyk D, Pitts W, Earl R, Hobbs F, Copeland R, Magolda R, et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998; 273:18623-18632.
14. Wang K, Zhang L, McMillen I, Botting K, Duffield J, Zhang S, Suter C, Brooks D, Morrison J. Fetal growth restriction and programming of heart growth and cardiac insulin-like growth factor 2 expression in the lamb. J Physiol 2011; 589:4709-4722.
15. Lebeche D, Kang Z, Hajjar R. Candesartan abrogates G protein-coupled receptors agonist-induced MAPK activation and cardiac myocyte hypertrophy. JRAAS 2001. 2(suppl):S154-S161.
16. Chu C, Tzang B, Chen L, Kuo C, Cheng Y, Chen L, Tsai F, Tsai C, Kuo W, Huang C. IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Gaq interaction and protein kinase C-a/CaMKII activation in H9c2 cardiomyoblast cells. J Endocrinol 2008; 197:381-390.
17. Huang C, Hao L, Buetow D. Hypertrophy of cultured adult rat ventricular cardiomyocytes induced by antibodies against the insulin-like growth factor (IGF)-I or the IGF-I receptor is IGF-II-dependent. Mol Cell Biochem 2002; 233:65-72.
18. Xia Y, Karmazyn M. Obligatory role for endogenous endothelin in mediating the hypertrophic effects of phenylephrine and angiotensin II in neonatal rat ventricular myocytes: evidence for two distinct mechanisms for endothelin regulation. J Pharmacol Exp Ther 2004; 310:43-51.
19. Rapacciuolo A, Esposito G, Caron K, Mao L, Thomas S, Rockman H. Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy. J Am Coll Cardiol 2001; 38:876-882.
20. Backs J, Backs T, Neef S, Kreusser M, Lehmann L, Patrick D. The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci U S A 2009; 106:2342-2347.
21. Zhang W, Qi F, Chen DQ, Xiao WY, Wang J, Zhu WZ. Ca2/calmodulindependent protein kinase IIdelta orchestrates G-protein-coupled receptor and electric field stimulation-induced cardiomyocyte hypertrophy. Clin Exp Pharmacol Physiol 2010; 37:795-802.
22. Barker D, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986; 327:1077-1081.
23. Kajantie E, Osmond C, Barker D, Forsen T, Phillips D, Eriksson J. Size at birth as a predictor of mortality in adulthood: a follow-up of 350 000 person-years. Int J Epidemiol 2005; 34:655-663.
24. Li F, Wang X, Capasso JM, Gerdes AM. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 1996; 28:1737-1746.
25. Jonker S, Zhang L, Louey S, Giraud G, Thornburg K, Faber J. Myocyte enlargement, differentiation, and proliferation kinetics in the fetal sheep heart. J Appl Physiol 2007; 102:1130-1142.
26. Bowman J, Steinberg S, Jiang T, Geenen D, Fishman G, Buttrick P. Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. J Clin Invest 1997; 100: 2189-2195.
27. Vijayan K, Szotek E, Martin J, Samarel A. Protein kinase C-a-induced hypertrophy of neonatal rat ventricular myocytes. Am J Physiol Heart Circ Physiol 2004; 287:H2777-H2789.
28. Liu Q, Chen X, MacDonnell S, Kranias E, Lorenz J, Leitges M, Houser S, Molkentin J. Protein kinase Ca, but not PKCb or PKCc, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach. Circ Res 2009; 105:194-200.
29. Donohue T, Dworkin L, Lango M, Fliegner K, Lango R, Benstein J, Slater W, Catanese V. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation 1994; 89:799-809.
30. Lavandero S, Foncea R, Pee`rez V, Sapag-Hagar M. Effect of inhibitors of signal transduction on IGF-1-induced protein synthesis associated with hypertrophy in cultured neonatal rat ventricular myocytes. FEBS Letters 1998; 422:193-196.
31. Bueno O, Molkentin J. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 2002; 91: 776-781.
32. D'Angelo DD, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, Dorn GW II. Transgenic Gaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A 1997; 94:8121-8126.
33. Roman B, Geenen D, Leitges M, Buttrick P. PKC-b is not necessary for cardiac hypertrophy. Am J Physiol Heart Circ Physiol 2001; 280: H2264-H2270.
34. Fryer L, Holness M, Decock J, Sugden M. Cardiac protein kinase C expression in two models of cardiac hypertrophy associated with an activated cardiac renin-angiotensin system: effects of experimental hyperthyroidism and genetic hypertension (the mRen-2 rat). J Endocrinol 1998; 158:27-33.
35. Heineke J, Molkentin J. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006; 7:589-600.
36. Gao L, Blair L, Marshall J. CaMKII-independent effects of KN93 and its inactive analog KN92: reversible inhibition of L-type calcium channels. Biochem Biophys Res Commun 2006; 345:1606-1610.
37. Nuss H, Houser S. Voltage dependence of contraction and calcium current in severely hypertrophied feline ventricular myocytes. J Mol Cell Cardiol 1991; 23:717-726.
38. Tombes R, Grant S, Westin E, Krystal G. G1 cell cycle arrest and apoptosis are induced in NIH 3T3 cells by KN-93, an inhibitor of CaMKII (the multifunctional Ca2/CaM kinase). Cell Growth Differ 1995; 6: 1063-1070.
39. Huang C, Hao L, Buetow D. Insulin-like growth factor-induced hypertrophy of cultured adult rat cardiomyocytes is L-type calcium channel-dependent. Mol Cell Biochem 2002; 231:51-59.
40. Zhang R, Khoo M, Wu Y, Yang Y, Grueter C, Ni G, Price EJ, Thiel W, Guatimosin S, Song L, Madu E, Shah A, et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 2005; 11: 409-417.
41. Boknik P, Heinroth-Hoffmanb I, Kirchhefer U, Knapp J, Linck B, Luss H, Muller T, Schmitz W, Brodde O, Neumann J. Enhanced protein phosphorylation in hypertensive hypertrophy. Cardiovasc Res 2001; 51: 717-728.
42. Shikha M, Ling H, Grimm M, Zhang T, Bers D, Brown J. Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signalling. J Cardiovasc Pharmacol 2010; 56:598-603.
43. Ramirez M, Zhao X, Schulmani H, Brown J. The nuclear dB isoform of Ca21/calmodulin-dependent protein kinase II regulates atrial natriuretic factor gene expression in ventricular myocytes. J Biol Chem 1997; 272: 31203-31208.
44. Cipolletta E, Monaco S, Maione A, Vitiello L, Campiglia P, Pastore L, Franchini C, Novellino E, Limongelli V, Bayer K, Means A, Rossi G, et al. Calmodulin-dependent kinase II mediates vascular smooth muscle cell proliferation and is potentiated by extracellular signal regulated kinase. Endocrinol 2010; 151:2747-2759.
45. Lu K, Armstrong S, Ginnan R, Singer H. Adhesion-dependent activation of CaMKII and regulation of ERK activation in vascular smooth muscle. Am J Physiol Cell Physiol 2005; 289:C1343-C1350.
46. Yue T, Gu J, Wang C, Reith A, Lee J, Mirabilei R, Kreutz R, Wang Y, Maleeffi B, Parsons A, Ohlstein E. Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy. J Biol Chem 2000; 275:37895-37901.
47. Esposito G, Prasad SV, Rapacciuolo A, Mao L, Koch WJ, Rockman HA. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload. Circulation 2001; 103:1453-1458.
48. Perrault R, Wright B, Storie B, Hatherell A, Zahradka P. Tyrosine kinaseindependent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor. Cell Signal 2011; 23:739-746.
49. Huang C, Hao L, Buetow D. Insulin-like growth factor-II induces hypertrophy of adult cardiomyocytes via two alternative pathways. Cell Biol Int 2002; 26:737-739.
50. Francis G, Ross M, Ballard F, Milner S, Senn C, McNeil K, Wallace J, King R, Wells J. Novel recombinant fusion protein analogues of insulinlike growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. J Mol Endocrinol 1992; 8:213-223.
51. Sakano K, Enjoh T, Numata F, Fujiwarat H, Marumoto Y, Higashihashi N, Sato Y, Perduell J, Fujita-Yamaguchi Y. The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor. J Biol Chem 1991; 266:20626-20635.
52. Bach L, Hsieh S, Sakano K, Fujiwara H, Perdue J, Rechler M. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6. J Biol Chem 1993; 268:9246-9254.
53. Oh Y, Muller H, Zhang H, Ling N, Rosenfeld R. Synthesis and characterization of IGF-II analogs: applications in the evaluation of IGF receptor function and IGF-independent actions of IGFBPs. Adv Exp Med Biol 1993; 343:41-54.
54. Sumi M, Kiuchi K, Ishikawa T, Ishii A, Hagiwara M, Nagatsu T, Hidaka H. The newly synthesized selective Ca2/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem Biophys Res Commun 1991; 181:968-975.
55. Martiny-Baron G, Kazanietz M, Mischak H, Blumberg P, Kochs G, Hug H, Marme D, Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 1993; 268: 9194-9197.